Post by Novartis

Progressive kidney diseases continue to place a significant burden on patients worldwide—often advancing quietly over time. At Novartis, we are committed to leading the transformation of kidney care by advancing science, deepening understanding of disease, and taking a long‑term approach to improving outcomes for people living with serious kidney conditions. As the global kidney community comes together ahead of the European Renal Association (ERA) Congress, our focus remains clear: protecting kidney health today while helping to shape the future of care. #ProtectingKidneysTransformingCare #KidneyDisease #IgAN #IgANephropathy #ERA26